Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Vimian Group AB ( (SE:VIMIAN) ) has provided an update.
Vimian Group AB is considering issuing a senior unsecured bond to raise EUR 125 million, with a potential framework of EUR 250 million, subject to market conditions. The proceeds will be used to refinance existing debt and support corporate activities, including acquisitions and investments, potentially impacting its financial strategy and market positioning.
More about Vimian Group AB
Vimian is a global animal health company specializing in four key areas: Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. Headquartered in Stockholm, Sweden, the company serves over 17,000 veterinary clinics and laboratories across more than 80 markets, employing 1,200 people with annual revenues of approximately EUR 375 million.
Average Trading Volume: 474,099
Current Market Cap: SEK19.38B
See more insights into VIMIAN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue